MS

Manjushri Sangle

Active Director Director DIN 07725773
DIN 07725773 First appointment Apr 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2017
Shareholding value •••• Premium profile

About Manjushri Sangle

Data last updated:

Manjushri Sangle is a Director at Byennet Pharmaceutical Private Limited (since 2017). The company operates in Pharma. Byennet Pharmaceutical Private Limited reported revenue of ₹38.6 Lakh (FY 2025).

DIN 07725773
Primary Designation Director
Industry Pharma
First Appointment 05 Apr 2017
Oldest Company Age 9 yrs
Largest company Byennet Pharmaceutical Private Limited · ₹38.6 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director05 Apr 20172017₹38.6 Lakh (FY 2025)Active

Board colleagues of Manjushri Sangle

NameDINCompanyDesignation
Balaji Tukaram Sangle07793005Byennet Pharmaceutical Private LimitedAdditional Director

Directorship timeline

Open interactive timeline →
Byennet Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Manjushri Sangle

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manjushri Sangle

Manjushri Sangle currently holds 1 directorship: Byennet Pharmaceutical Private Limited (Director, since 05 Apr 2017, revenue ₹38.6 Lakh (FY 2025)).

Manjushri Sangle was first appointed on 05 Apr 2017 as Director at Byennet Pharmaceutical Private Limited.

The current boards of Manjushri Sangle's companies include Balaji Tukaram Sangle (Byennet Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available